Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia

ClinicalTrials.gov ID: NCT01328002

Public ClinicalTrials.gov record NCT01328002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Placebo-Controlled Withdrawal Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacokinetics of milnacipran in pediatric patients aged 13 to 17 years with primary fibromyalgia.

Study identification

NCT ID
NCT01328002
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
116 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011 (Actual)
Primary completion
Aug 31, 2012 (Actual)
Completion
Aug 31, 2012 (Actual)
Last update posted
May 14, 2019

2011 – 2012

United States locations

U.S. sites
47
U.S. states
23
U.S. cities
41
Facility City State ZIP Site status
Forest Investigative Site 040 Birmingham Alabama 35205 —
Forest Investigative Site 068 Birmingham Alabama 35216 —
Forest Investigative Site 033 Bullhead City Arizona 86442 —
Forest Investigative Site 012 Fresno California 93710 —
Forest Investigative Site 045 Fresno California 93720 —
Forest Investigative Site 051 Fresno California 93721 —
Forest Investigative Site 035 Orange California 92868 —
Forest Investigative Site 053 Orange California 92868 —
Forest Investigative Site 050 Sacramento California 95825 —
Forest Investigative Site 034 Colorado Springs Colorado 80907 —
Forest Investigative Site 047 Cromwell Connecticut 06416 —
Forest Investigative Site 061 Gainesville Florida 32607 —
Forest Investigative Site 041 Orange City Florida 32763 —
Forest Investigative Site 059 Orlando Florida 32806 —
Forest Investigative Site 014 Spring Hill Florida 34609 —
Forest Investigative Site 055 West Palm Beach Florida 33409 —
Forest Investigative Site 058 Blue Ridge Georgia 30513 —
Forest Investigative Site 031 Savannah Georgia 31406 —
Forest Investigative Site 022 Chicago Illinois 60634 —
Forest Investigative Site 010 Peoria Illinois 61614 —
Forest Investigative Site 005 Indianapolis Indiana 46250 —
Forest Investigative Site 017 Louisville Kentucky 40202 —
Forest Investigative Site 009 Ann Arbor Michigan 48104 —
Forest Investigative Site 024 Rochester Hills Michigan 48307 —
Forest Investigative Site 036 Stevensville Michigan 49127 —
Forest Investigative Site 049 Whitehouse Station New Jersey 08889 —
Forest Investigative Site 018 Albuquerque New Mexico 87109 —
Forest Investigative Site 062 Raleigh North Carolina 27612 —
Forest Investigative Site 052 Winston-Salem North Carolina 27103 —
Forest Investigative Site 038 Akron Ohio 44308 —
Forest Investigative Site 016 Cincinnati Ohio 45219 —
Forest Investigative Site 015 Dayton Ohio 45432 —
Forest Investigative Site 019 Middleburg Heights Ohio 44130 —
Forest Investigative Site 001 Oklahoma City Oklahoma 73112 —
Forest Investigative Site 027 Oklahoma City Oklahoma 73112 —
Forest Investigative Site 066 Mechanicsburg Pennsylvania 17055 —
Forest Investigative Site 054 Philadelphia Pennsylvania 19139 —
Forest Investigative Site 046 Greer South Carolina 29650 —
Forest Investigative Site 023 Austin Texas 78732 —
Forest Investigative Site 003 San Antonio Texas 78215 —
Forest Investigative Site 042 San Antonio Texas 78258 —
Forest Investigative Site 025 Clinton Utah 84015 —
Forest Investigative Site 013 Salt Lake City Utah 84102 —
Forest Investigative Site 021 Lynchburg Virginia 24503 —
Forest Investigative Site 006 Bellevue Washington 98007 —
Forest Investigative Site 063 Seattle Washington 98104 —
Forest Investigative Site 004 Racine Wisconsin 53406 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01328002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01328002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →